Myriad Genetics Inc (NASDAQ:MYGN)

32.98
BATS BZX Real-Time Price
As of 1:39pm ET
 +0.02 / +0.06%
Today’s Change
31.56
Today|||52-Week Range
40.50
-3.17%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close32.96
Today’s open32.82
Day’s range32.56 - 33.13
Volume193,528
Average volume (3 months)675,095
Market cap$2.3B
Dividend yield--
Data as of 1:27pm ET, 06/02/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-40.00%
Earnings growth (next 5 years)+13.17%
Revenue growth (last year)+26.92%
P/E ratio26.3
Price/Sales3.31
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
--COSMO Pharmaceutical...+1.20+0.75%
GLPGGalapagos NV-0.23-0.39%
TSROTESARO Inc-1.89-3.11%
MNKDMannkind Corp+0.10+1.94%
Data as of 1:43pm ET, 06/02/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers